NCT06831383 - The STOP-HPV Scale Up Study | Biotech Hunter

Enrollment

100,000

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Human Papilloma Virus Vaccine

Interventions

BEHAVIORAL

STOP-HPV-Online

Approximately one third of practices within a participating health system will be randomized to receiving the STOP-HPV-Online intervention.

BEHAVIORAL

STOP-HPV-LC

Approximately one third of practices within a participating health system will be randomized to receiving the STOP-HPV-LC intervention.

All Listed Sponsors

collaborator

American Medical Group Association

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Los Angeles

OTHER